<< Back to Epigenetics on Target Home Page
Bromodomains in Epigenetics and Disease
Bromodomains are evolutionarily conserved protein modules that recognize and bind to acetylated lysine residues, primarily on histone tails. This binding allows bromodomain-containing proteins to function as epigenetic "readers", helping to regulate gene expression, chromatin structure, and transcriptional activation. Many of these proteins play central roles in transcriptional coactivation, chromatin remodeling, or histone acetylation, and are frequently implicated in cancer, neurological disorders, and inflammatory diseases. Notably, BET family proteins (BRD2, BRD3, BRD4, BRDT) are the most well-characterized, with BRD4 emerging as a high-value drug target in oncology. Other bromodomain proteins such as CBP/p300, SMARCA4, and PBRM1 also serve as tumor suppressors or oncogenic cofactors, making them crucial to understanding and manipulating epigenetic regulation in disease.
| Protein / Family | Epigenetic Function | Disease Association | Key Publications | Key Products |
|---|---|---|---|---|
| ATAD2 | Binds acetylated histones; oncogenic co-activator for MYC | Breast, liver, lung cancers | Biju et al., Int J Biol Macromol. 2025 Han et al., Blood. 2025 |
Antibodies |
| BAZ1B (WSTF) | Chromatin assembly, transcription regulation, DNA repair | Williams-Beuren syndrome | Pai et al., Dev Biol. 2024 Kim et al., Nat Commun. 2024 |
|
| BRD1 | Component of the MOZ/MORF HAT complex; interacts with acetylated histones; coactivates nuclear receptors; regulates gene expression during development | Schizophrenia, bipolar disorder, depression, and some cancers (e.g. breast) | Zhang et al., Cell Death Dis. 2025 Wang et al., Sci Transl Med. 2024 |
Proteins |
| BRD2 (BET) | Transcriptional regulation; binds acetylated histones | Obesity, epilepsy, B-cell lymphoma | Wang et al., Biochem J. 2009 Pathak et al., Epilepsia 2018 Zou et al., Cell Biosci. 2024 |
Antibodies Proteins |
| BRD3 (BET) | Chromatin binding; transcriptional regulation | NUT midline carcinoma (BRD3-NUT fusion) | Hwang et al., Diagn Cytopathol. 2023 Hashimoto et al., Cancer Sci. 2024 |
Antibodies Proteins |
| BRD4 (BET) | Recognizes acetyl-H3/H4; recruits P-TEFb for transcriptional elongation | AML, NUT carcinoma, breast cancer, inflammation | Umphred-Wilson et al., Nat Commun. 2025 Fan et al., Nat Commun. 2025 Zhang et al., Cell Rep. 2024 Cameron et al., Sci Adv. 2023 |
Antibodies Proteins |
| BRD7 | Part of PBAF; cofactor of p53; chromatin remodeling | Breast, colorectal cancer | Mondal et al., Nat Commun. 2025 Guo et al., Int J Biol Sci. 2025 |
Antibodies Proteins |
| BRD8 | Part of the NuA4/TIP60 histone acetyltransferase complex; binds acetylated histones and regulates DNA repair, chromatin remodeling, and transcription | Overexpressed in colorectal and hepatocellular carcinomas; potential role in tumor progression and chromatin instability | Wu et al., Eur J Med Chem. 2024 Yamaguchi et al., Cancer Sci. 2024 |
Proteins |
| BRD9 | Non-BET; part of ncBAF SWI/SNF complex | AML, multiple myeloma | Lee et al., Nuc Acids Res. 2025 Lv et al., Cell Death Dis. 2025 |
Antibodies Proteins |
| BRDT (BET) | Testis-specific; chromatin remodeling in spermatogenesis | Male infertility; contraceptive target | F. Pietra, Chemistry Europe 2024 Zheng et al., Sci Adv. 2025 |
Proteins |
| CBP (CREBBP) | Histone acetyltransferase; bromodomain recognizes acetyl marks | Rubinstein-Taybi syndrome, lymphomas | Chen et al., J Neuropathol Exp Neurol. 2025 Liu et al., bioRxiv 2025 |
Antibodies Proteins Kits |
| p300 (EP300) | Transcription coactivator and HAT; acetylates histones and TFs | Colorectal, bladder, and hematological cancers | Sasaki et al., Nat Commun. 2024 Xu et al., Acta Neuropathol Commun. 2024 Compton et al., Mol Cell 2023 |
Antibodies Proteins |
| PBRM1 | Contains 6 bromodomains; tumor suppressor in PBAF complex | Clear cell renal cell carcinoma | Lane et al., Nat Commun. 2025 Yao et al., Nat Cell Biol. 2023 Petell et al., J Biol Chem. 2023 |
Antibodies Proteins |
| SMARCA1 (SNF2L1) | ISWI-family chromatin remodeler; regulates nucleosome spacing and compaction; modulates gene accessibility during differentiation | Dysregulated in glioma, prostate, and other cancers; implicated in neuronal development and X-inactivation escape | Nishimura et al., J Hum Genet. 2025 Fu et al., bioRxiv 2024 |
Antibodies |
| SMARCA2 (BRM) | Similar to SMARCA4; SWI/SNF remodeling | Silenced in lung and other cancers | Papavassiliou et al., Trends Cancer. 2025 Guo et al., Eur J Med Chem. 2025 Deng et al., Pathol Res Pract. 2025 |
Antibodies Proteins |
| SMARCA4 (BRG1) | ATPase in SWI/SNF complex; chromatin remodeling | Lung, ovarian, pediatric brain cancers | Ye et al., Cancer Lett. 2025 Wang et al., Cancer Res. 2025 Papavassiliou et al., Trends Cancer. 2025 |
Antibodies Proteins |
| SMARCAL1 / HARP | Chromatin-associated annealing helicase; stabilizes stalled replication forks; aids chromatin structure restoration after replication stress | Causative mutations in Schimke Immuno-Osseous Dysplasia (SIOD); linked to genome instability in cancer and DNA damage response defects | Oak et al., medRxiv 2025 Zhao et al., Sci Rep. 2025 |
Antibodies |
| TAF1 | TFIID subunit; bromodomains recognize acetylated promoters | X-linked dystonia-parkinsonism | Chen et al., Mol Cancer Ther. 2025 Burgos et al., bioRxiv 2025 |
Proteins |
Additional Resources
- [Blog] BRD4 and SNA1e Combine to Increase Cancer Cell Aggression: Using CRISPR screening as a Tool
- [Blog] Monkeying Around with Transcription? How CHMP5 Promotes Leukemia Development via BRD4 and p300
- [Podcast] How BRD4 and H2BE Influence Neuronal Activity (Erica Korb)
